(A) The distribution of mutations within the 3D structure of the TP53 protein. by Ashraf Attia Mahmoud (21262201)

Subjects:

Variables of trees located at coordinates . by Alexandra M. Campbell (3284094)

Subjects:

Global parameters and variables for the model. by Alexandra M. Campbell (3284094)

Subjects:

Variables of patch located at coordinates . by Alexandra M. Campbell (3284094)

Subjects:

MRSP Data collected in March 2018. by Alexandra M. Campbell (3284094)

Subjects:

HSF2 expression sustains KSHV infection in KLEC. by Lorenza Cutrone (21144285)

Subjects:

Primers used in ChIP-PCR. by Lorenza Cutrone (21144285)

Subjects:

Primers used in RTqPCR. by Lorenza Cutrone (21144285)

Subjects:

HSF2 regulates ORF50 expression in an RTA independent manner. by Lorenza Cutrone (21144285)

Subjects:

HSF2 regulates lytic gene expression in latency and during the lytic phase. by Lorenza Cutrone (21144285)

Subjects:

ABM NetLogo File. by Alexandra M. Campbell (3284094)

Subjects:

HEK.219 cells were treated with the indicated siRNAs for 24h. by Lorenza Cutrone (21144285)

Subjects:

HSF2 binds the ORF50 promoter and remodels the local chromatin landscape. by Lorenza Cutrone (21144285)

Subjects:

Top 10 significant functional annotations of up-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance according to the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

Top 10 significant functional annotations of down-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

HSF2 is degraded during KSHV lytic reactivation. by Lorenza Cutrone (21144285)

Subjects:

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

Subjects:

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

Subjects:

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

Subjects:

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects: